Navigation Links
Chemists identify key gene in development of type 1 diabetes

Chemists say they have identified a gene that appears to play a key role in the development of type 1 diabetes, also known as insulin-dependent or juvenile diabetes, a disease that affects about one million people in the U.S. and is on the rise worldwide. They described their findings, which they say could lead to new drug interventions and possibly gene therapy, today at the 229th national meeting of the American Chemical Society, the world's largest scientific society.

In the current study, the researchers focused on the formation of the MIF protein (macrophage migration inhibitory factor), a proinflammatory protein that they showed in previous studies is elevated in diabetic animals and may be involved in the cascade of immunological events that leads to the destruction of the pancreas and the subsequent onset of type 1 diabetes. The disease is much less common than type 2 diabetes, formerly known as adult onset or non-insulin-dependent diabetes, which is often associated with obesity.

"We've shown that the MIF gene is crucial for the development of type 1 diabetes," says study leader Yousef Al-Abed, Ph.D., a chemist at the Institute for Medical Research of the North Shore-Long Island Jewish (LIJ) Health System in Manhasset, N.Y. "It is not the only factor involved in this complex disease, but it is certainly a promising target for its prevention and treatment."

In preliminary studies by the research group, specially bred mice that lacked the gene for the MIF protein failed to develop diabetes compared to mice that possessed the gene, according to the investigators. Although it's likely that multiple genes are involved in the formation of diabetes, the finding provides proof of concept that efforts to block the formation of this particular protein is a promising approach for fighting diabetes, they say.

"The MIF gene may be regulating other genes involved in type 1 diabetes," says Al-Abed. "We don't know yet, but we're looking into
'"/>

Source:American Chemical Society


Page: 1 2 3

Related biology news :

1. Chemists create Superbowl molecule; May lead to better health
2. Duke Chemists Isolating Individual Molecules Of Toxic Protein In Alzheimers, Parkinsons Disease
3. Chemists identify immune system mechanism for methamphetamine binges
4. Chemists synthesize molecule that helps body battle cancers, malaria
5. Fox Chase Cancer Center scientists identify immune-system mutation
6. Researchers identify target for cancer drugs
7. Scientists identify genetic pathways essential to RNA interference
8. Scientists identify molecular events that drive cell senescence
9. Scientists identify new model Of NK cell development
10. Yale researchers identify molecule for detecting parasitic infection in humans
11. Wisconsin researchers identify sleep gene

Post Your Comments:
(Date:11/19/2009)... brain chemical with an unwieldy name: 4-hydroxybu... used as a date-rape drug. , Now, a team of Ohi...es by which 4-HB is metabolized by the body. "This...l Gibson, professor and chair of biological scienc...er of the research team. "It may provide new clue...
(Date:11/19/2009)... which cultivate fungus for food, have many remark...e list: the ant farmers, like their human counterp...heir gardens grow. The finding, reported this week...reviously unknown symbiosis between ants and bacte... have come to dominate the American tropics and su...
(Date:11/19/2009)... in many countries of the world. It is widely used...l materials. It also is considered an exemplar pla...volution, and genome architecture. The authors of ...used the first description of the B73 maize genome... genetics and plant biology. The ten papers consid...
Breaking Biology News(10 mins):Researchers begin to decipher metabolism of sexual assault drug 2Like humans, ants use bacteria to make their gardens grow 2PLoS Genetics 2009 maize genome collection 2PLoS Genetics 2009 maize genome collection 3PLoS Genetics 2009 maize genome collection 4CSHL study finds short and long term memories require same gene but in different circuits 9605 1CSHL study finds short and long term memories require same gene but in different circuits 9605 2CSHL study finds short and long term memories require same gene but in different circuits 9605 3Blood Pressure Drug Might Work Against MS 54677 1Blood Pressure Drug Might Work Against MS 54677 2Blood Pressure Drug Might Work Against MS 54677 3Worries May Worsen Peripheral Arterial Disease 54672 1Worries May Worsen Peripheral Arterial Disease 54672 2
...NY May 9, 2008 Autism Speaks, the worlds largest ...ormation of an international collaboration with No... initiative will help to raise awareness and devel...d screening for early diagnosis and enhanced servi...is important to form partnerships with countries t...
... Calif. - The radioactive carbon-14 produced by ab...as helped researchers determine that the number of...e, is established during the teenage years. Change...y to changes in fat cell volume, not an increase i... could help researchers develop new pharmaceutical...
...y of the molecular mechanisms by which plants prot...bsorb too much sunlight during photosynthesis, a t...er switch that helps control the flow of solar ene...proteins. This discovery holds important implicati...esis systems that could provide the world with a s...
Other Biology News:Autism Speaks announces multinational initiative 2New technique determines the number of fat cells remains constant in all body types 2New technique determines the number of fat cells remains constant in all body types 3Berkeley researchers identify photosynthetic dimmer switch 2Berkeley researchers identify photosynthetic dimmer switch 3Berkeley researchers identify photosynthetic dimmer switch 4
(Date:11/20/2009)...O recently announced that Dr. Dominique Hebrault w...cess Analytical Technology (PAT) in Green Chemistr.... , (PRWEB) November 20, ... Technology (PAT) in Green Chemistry and Green Eng...l Technology (PAT) case studies will be presented ...
(Date:11/19/2009)...re/ -- Danish Prince Joachim inaugurated the DONG ...undborg, Denmark, on Wednesday, November 18. The f...d generation ethanol demonstration biorefineries. ...nt,s innovative process for converting straw to fu... to market with commercial enzymes for converting ...
(Date:11/19/2009)...ewswire/ -- Dr. Mate Hidvegi, inventor of Avemar f...elease issued on November 17 by Biropharma Kft, di...and self-serving statements about its U.S. competi...d from his office in Budapest, Hungary: ,, "Th...t apply to AveULTRA, www.aveultra.com , is misl...
(Date:11/19/2009)...e-FirstCall/ -- NeoStem, Inc. (NYSE Amex: NBS ), ...ter to its shareholders, discussing the Company,s ...maceuticals Holdings, Inc. (CHBP), an integrated b...public of China. The merger gives NeoStem a contro...o. Ltd., CHBP,s primary operating subsidiary and a...
Breaking Biology Technology:Process Analytical Technology (PAT) in Green Chemistry and Green Engineering 2DONG Energy and Inbicon Inaugurate One of the World's Largest Demo Plants for 2nd Generation Biofuel 2American BioSciences Rebuts Misleading Statements Made by Hungarian Competitor 2NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 2NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 3
...in Board: PLMO) announced today that it has increa...its total holdings to 61% in this Company,which ow... for pulmonary,related medical conditions., Pulmo...the Molecular,Imaging technology, developed and ow...the diagnosis of Pulmonary Embolism and Pulmonary ...
...emerging,leader in the development of implantable ...ations, announced today the addition of Jon Tremme...m Medtronic Inc. after nearly 30 years of service,...ncluding President of the,Neurological Division, P...,of the Tachyarrhythmia Management Division and Pr...
...ng costs drive solid ea...er Chilcott,Limited (Nasdaq: WCRX ) today announc...8. Revenue in the quarter ended March 31, 2008 tot... prior year quarter. The primary,drivers of the in...ed,products LOESTRIN 24 FE, DORYX, TACLONEX and FE...
Other Biology Technology:Pulmo BioTech Announces an Increase in its Stake in PulmoScience 2Pulmo BioTech Announces an Increase in its Stake in PulmoScience 3InSet Technologies Appoints Jon Tremmel to its Board of Directors 2Warner Chilcott Reports Operating Results for the Quarter ended March 31, 2008 and Updates 2008 Full Year Guidance 2Warner Chilcott Reports Operating Results for the Quarter ended March 31, 2008 and Updates 2008 Full Year Guidance 3Warner Chilcott Reports Operating Results for the Quarter ended March 31, 2008 and Updates 2008 Full Year Guidance 4Warner Chilcott Reports Operating Results for the Quarter ended March 31, 2008 and Updates 2008 Full Year Guidance 5Warner Chilcott Reports Operating Results for the Quarter ended March 31, 2008 and Updates 2008 Full Year Guidance 6Warner Chilcott Reports Operating Results for the Quarter ended March 31, 2008 and Updates 2008 Full Year Guidance 7Warner Chilcott Reports Operating Results for the Quarter ended March 31, 2008 and Updates 2008 Full Year Guidance 8Warner Chilcott Reports Operating Results for the Quarter ended March 31, 2008 and Updates 2008 Full Year Guidance 9Warner Chilcott Reports Operating Results for the Quarter ended March 31, 2008 and Updates 2008 Full Year Guidance 10Warner Chilcott Reports Operating Results for the Quarter ended March 31, 2008 and Updates 2008 Full Year Guidance 11Warner Chilcott Reports Operating Results for the Quarter ended March 31, 2008 and Updates 2008 Full Year Guidance 12Warner Chilcott Reports Operating Results for the Quarter ended March 31, 2008 and Updates 2008 Full Year Guidance 13Warner Chilcott Reports Operating Results for the Quarter ended March 31, 2008 and Updates 2008 Full Year Guidance 14Warner Chilcott Reports Operating Results for the Quarter ended March 31, 2008 and Updates 2008 Full Year Guidance 15Warner Chilcott Reports Operating Results for the Quarter ended March 31, 2008 and Updates 2008 Full Year Guidance 16Warner Chilcott Reports Operating Results for the Quarter ended March 31, 2008 and Updates 2008 Full Year Guidance 17
Mouse Anti-Human CCL26 / Eotaxin-3 Monoclonal Antibody, Unconjugated, Clone 115002 from R&D Systems
Goat Anti-Human TFPI Polyclonal Antibody, Unconjugated from R&D Systems
TMB Slow Kinetic One Component HRP Microwell Substrate from BioFX Laboratories, Inc.
Eppendorf tube holder, for Tube rack 175 x 12 mm from GE Healthcare, formerly Amersham Biosciences
Biology Products: